Search research articles
Contact Us
Filters
Showing results (31-40 of 127) with videos related to
Page
of 13
Sort By:
Cancer Chemotherapy and Pharmacology
|
November 12, 2005
Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme
Anne F Schott, James M Rae, Kent A Griffith, et al.
Pharmacogenomics and Personalized Medicine
|
March 22, 2021
Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus
Amy L Pasternak, Vincent D Marshall, Christina L Gersch, et al.
Pharmacogenetics
|
August 2, 2003
Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples
James M Rae, Kevin E Cordero, Joshua O Scheys, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 13, 2006
Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells
Young Chai Lim, Lang Li, Zeruesenay Desta, et al.
Breast Cancer Research and Treatment
|
September 21, 2004
EGFR and EGFRvIII expression in primary breast cancer and cell lines
James M Rae, Joshua O Scheys, Kim M Clark, et al.
Breast Cancer Research and Treatment
|
June 30, 2005
GREB 1 is a critical regulator of hormone dependent breast cancer growth
James M Rae, Michael D Johnson, Joshua O Scheys, et al.
Breast Cancer Research and Treatment
|
June 4, 2008
The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance
Matthew J Sikora, Kevin E Cordero, Jose M Larios, et al.
Hormones & Cancer
|
October 8, 2011
Functional characterization of a genetic polymorphism in the promoter of the ESR2 gene
Santosh Philips, Alexandra Richter, Steffi Oesterreich, et al.
JAMIA Open
|
January 22, 2024
Incorporation of emergent symptoms and genetic covariates improves prediction of aromatase inhibitor therapy discontinuation
Ilia Rattsev, Vered Stearns, Amanda L Blackford, et al.
Pharmacogenomics
|
July 30, 2020
DNA derived from archival tumor specimens can be used for germline pharmacogenetic analyses
Daniel L Hertz, Kelley M Kidwell, Julie A Douglas, et al.
Page
of 13
Search research articles
Search
Showing results (31-40 of 127) with videos related to
Sort By:
Page
of 13
Cancer Chemotherapy and Pharmacology
|
November 12, 2005
Combination vinorelbine and capecitabine for metastatic breast cancer using a non-body surface area dosing scheme
Anne F Schott, James M Rae, Kent A Griffith, et al.
Pharmacogenomics and Personalized Medicine
|
March 22, 2021
Evaluating the Impact of CYP3A5 Genotype on Post-Transplant Healthcare Resource Utilization in Pediatric Renal and Heart Transplant Recipients Receiving Tacrolimus
Amy L Pasternak, Vincent D Marshall, Christina L Gersch, et al.
Pharmacogenetics
|
August 2, 2003
Genotyping for polymorphic drug metabolizing enzymes from paraffin-embedded and immunohistochemically stained tumor samples
James M Rae, Kevin E Cordero, Joshua O Scheys, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 13, 2006
Endoxifen, a secondary metabolite of tamoxifen, and 4-OH-tamoxifen induce similar changes in global gene expression patterns in MCF-7 breast cancer cells
Young Chai Lim, Lang Li, Zeruesenay Desta, et al.
Breast Cancer Research and Treatment
|
September 21, 2004
EGFR and EGFRvIII expression in primary breast cancer and cell lines
James M Rae, Joshua O Scheys, Kim M Clark, et al.
Breast Cancer Research and Treatment
|
June 30, 2005
GREB 1 is a critical regulator of hormone dependent breast cancer growth
James M Rae, Michael D Johnson, Joshua O Scheys, et al.
Breast Cancer Research and Treatment
|
June 4, 2008
The androgen metabolite 5alpha-androstane-3beta,17beta-diol (3betaAdiol) induces breast cancer growth via estrogen receptor: implications for aromatase inhibitor resistance
Matthew J Sikora, Kevin E Cordero, Jose M Larios, et al.
Hormones & Cancer
|
October 8, 2011
Functional characterization of a genetic polymorphism in the promoter of the ESR2 gene
Santosh Philips, Alexandra Richter, Steffi Oesterreich, et al.
JAMIA Open
|
January 22, 2024
Incorporation of emergent symptoms and genetic covariates improves prediction of aromatase inhibitor therapy discontinuation
Ilia Rattsev, Vered Stearns, Amanda L Blackford, et al.
Pharmacogenomics
|
July 30, 2020
DNA derived from archival tumor specimens can be used for germline pharmacogenetic analyses
Daniel L Hertz, Kelley M Kidwell, Julie A Douglas, et al.
Page
of 13